Syncona Portfolio LTD Autolus Therapeutics PLC Transaction History
Syncona Portfolio LTD
- $85.9 Million
- Q2 2024
A detailed history of Syncona Portfolio LTD transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Syncona Portfolio LTD holds 21,346,829 shares of AUTL stock, worth $77.5 Million. This represents 86.45% of its overall portfolio holdings.
Number of Shares
21,346,829
Previous 21,346,829
-0.0%
Holding current value
$77.5 Million
Previous $136 Million
45.45%
% of portfolio
86.45%
Previous 90.76%
Shares
2 transactions
Others Institutions Holding AUTL
# of Institutions
114Shares Held
167MCall Options Held
34.2KPut Options Held
19.5K-
Blackstone Inc New York, NY20.5MShares$74.4 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA17.9MShares$64.9 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$55.4 Million1.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$44.8 Million0.59% of portfolio
-
Tfg Asset Management Gp LTD Grand Cayman, E98MShares$29 Million9.47% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $330M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...